- Home
- SBFM vs MFC Comparison
SBFM vs MFC Comparison
Compare SBFM & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MFC
- Stock Information
- Founded
- SBFM 2006
- MFC 1887
- Country
- SBFM United States
- MFC Canada
- Employees
- SBFM N/A
- MFC N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MFC Life Insurance
- Sector
- SBFM Health Care
- MFC Finance
- Exchange
- SBFM Nasdaq
- MFC Nasdaq
- Market Cap
- SBFM 6.6M
- MFC 51.7B
- IPO Year
- SBFM N/A
- MFC 1999
- Fundamental
- Price
- SBFM $1.50
- MFC $31.90
- Analyst Decision
- SBFM Strong Buy
- MFC Buy
- Analyst Count
- SBFM 1
- MFC 1
- Target Price
- SBFM $15.00
- MFC $49.00
- AVG Volume (30 Days)
- SBFM 44.5K
- MFC 2.2M
- Earning Date
- SBFM 11-04-2025
- MFC 11-05-2025
- Dividend Yield
- SBFM N/A
- MFC 3.83%
- EPS Growth
- SBFM N/A
- MFC 33.03
- EPS
- SBFM N/A
- MFC 2.29
- Revenue
- SBFM $36,341,741.00
- MFC $22,915,108,577.00
- Revenue This Year
- SBFM $32.20
- MFC $34.27
- Revenue Next Year
- SBFM $32.74
- MFC $8.25
- P/E Ratio
- SBFM N/A
- MFC $13.55
- Revenue Growth
- SBFM 19.22
- MFC 9.72
- 52 Week Low
- SBFM $1.17
- MFC $25.92
- 52 Week High
- SBFM $3.90
- MFC $33.07
- Technical
- Relative Strength Index (RSI)
- SBFM 56.84
- MFC 65.44
- Support Level
- SBFM $1.35
- MFC $30.49
- Resistance Level
- SBFM $1.45
- MFC $31.04
- Average True Range (ATR)
- SBFM 0.07
- MFC 0.44
- MACD
- SBFM 0.01
- MFC 0.17
- Stochastic Oscillator
- SBFM 82.39
- MFC 99.07
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About MFC Manulife Financial Corporation
Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 22% of adjusted earnings. The Asia segment operates across 12 countries and contributes around 36% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 23% of earnings and is one of the top 20 life insurers in the US. Manulife's global asset and wealth management business contributes approximately 20% of its earnings and had around CAD 1.03 trillion in assets under management and administration as of the end of 2024.